ScholarIQanswers from OpenAlex & ORCID
Marc Feldmann
ResearcherPublications, citations & collaboration network
Marc Feldmann is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marc Feldmann have?
ScholarIQindexed works
Marc Feldmann has 710 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marc Feldmann have?
ScholarIQcitation count
Marc Feldmann has 69,800 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marc Feldmann?
ScholarIQh-index
Marc Feldmann has an h-index of 129 in OpenAlex.
What is the i10-index of Marc Feldmann?
ScholarIQi10-index
Marc Feldmann has an i10-index of 460 in OpenAlex.
What is the ORCID of Marc Feldmann?
ScholarIQorcid
The ORCID for Marc Feldmann is on the source record.
What is the OpenAlex record for Marc Feldmann?
ScholarIQopenalex
The OpenAlex for Marc Feldmann is on the source record.
What are the most-cited papers on Marc Feldmann?
ScholarIQmost cited works
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, Daniel E. Fürst, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Michael H. Weisman, Paul Emery, Marc Feldmann, Gregory R. Harriman, Ravinder N. Maini
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, Daniel E. Fürst, Joachim R. Kalden, Michael H. Weisman, Josef S. Smolen, Paul Emery, Gregory R. Harriman, Marc Feldmann, Peter E. Lipsky
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
Michael J. Elliott, Ravinder N. Maini, Marc Feldmann, Joachim R. Kalden, Christian Antoni, Josef S Smolen, Burkhard F. Leeb, F. C. Breedveld, J. D. Macfarlane, J. A. Bijl, James N. Woody
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
Ravinder N. Maini, Ferdinand C. Breedveld, Joachim R. Kalden, Josef S Smolen, Diana Davis, J. D. Macfarlane, Christian Antoni, Burkhard F. Leeb, Michael J. Elliott, James N. Woody, T Schaible, Marc Feldmann
Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis
Claudia Monaco, Evangelos Andreakos, Serafim Kiriakidis, Claudia Mauri, Colin Bicknell, Brian M. J. Foxwell, Nicholas Cheshire, Ewa Paleolog, Marc Feldmann